Yuki Haga

4PUBLICATIONS
35CO-AUTHORS
Molecular targetsElectrochemical energy storage and conversionPredictive and prognostic markersCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 08, 2024
Silmitasertib in Combination With Cabozantinib Impairs Liver Cancer Cell Cycle Progression, Induces Apoptosis, and Delays Tumor Growth in a Preclinical Model.

Yuki Haga, Ranjit Ray, Ratna B Ray

|Dec 12, 2023
Hepatitis C virus modified sE2<sub>F442NYT</sub> as an antigen in candidate vaccine facilitates human immune cell activation.

Yuki Haga, Keith Meyer, Molly M H Sung

|Oct 05, 2023
A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH Study.

Kazufumi Kobayashi, Sadahisa Ogasawara, Susumu Maruta

|Dec 31, 2014
IFNL4 ss469415590 Variant Is Associated with Treatment Response in Japanese HCV Genotype 1 Infected Individuals Treated with IFN-Including Regimens.

Tatsuo Miyamura, Tatsuo Kanda, Shingo Nakamoto

Pageof 1

Frequent Collaborators

2 joint publications

Ranjit Ray

1 joint publications

Tetsuhiro Chiba

1 joint publications

Kazufumi Kobayashi

1 joint publications

Sadahisa Ogasawara